Neuroendocrine-immune perturbations in metabolic disease: pathophysiological mechanisms underlying cognitive impairment
Frontiers in Human Neuroscience · 13.07.2026 · 20
DOI: 10.3389/fnhum.2026.1857087 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Human Neuroscience, online erschienen am 13.07.2026. Verfasst von Aviva Fraer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 383 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIDDK NIH HHS.
Abstract (Originalsprache)
The escalating global prevalence of obesity and associated metabolic disorders has catalyzed intensive investigation into their multisystemic ramifications. Recent scientific investigations elucidate the sophisticated bidirectional relationship between systemic metabolic aberrations and central nervous system (CNS) dysfunction, orchestrated via complex neuro–immune–endocrine signaling cascades. This integrative analysis consolidates extant literature regarding the mechanisms by which adiposity, metabolic-associated steatotic liver disease (MASLD), and systemic metabolic perturbations disrupt neuro–immune–endocrine communication networks, consequently precipitating neuroinflammatory processes, cognitive dysfunction, and enhanced vulnerability to neurodegenerative disorders. We examine the molecular and cellular mechanisms underlying this pathophysiological cascade, including adipokine dysregulation, systemic inflammatory mediator elevation, hypothalamic inflammation, microglial activation, blood-brain barrier disruption, and subsequent neuronal dysfunction. Furthermore, we analyze the modulatory roles of key endocrine axes—including the hypothalamus, the pituitary and the adrenal glands-, and growth hormone/insulin-like growth factor systems—in metabolic-neural crosstalk. By elucidating these complex pathways, we aim to highlight mechanistically informed therapeutic targets and combinatorial strategies that may attenuate neuroinflammatory processes and cognitive deterioration in metabolically compromised individuals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
- Iowa Neuroscience Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
- Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, IA, United States.
- Iowa City VA Health Care System, Iowa City, IA, United States.
Förderung
- BLRD VA
- NIDDK NIH HHS
Zitieren
APA
Fraer, A., Saleh, S., Tasabehji, D., Sharma, D. S., & Mokadem, M. (2026). Neuroendocrine-immune perturbations in metabolic disease: pathophysiological mechanisms underlying cognitive impairment. Frontiers in Human Neuroscience, 20. https://doi.org/10.3389/fnhum.2026.1857087
Vancouver
Fraer A, Saleh S, Tasabehji D, Sharma DS, Mokadem M. Neuroendocrine-immune perturbations in metabolic disease: pathophysiological mechanisms underlying cognitive impairment. Frontiers in Human Neuroscience. 2026;20. doi:10.3389/fnhum.2026.1857087
BibTeX
@article{Fraer2026,
author = {Fraer, Aviva and Saleh, Sanaz and Tasabehji, Dana and Sharma, Durga Shankar and Mokadem, Mohamad},
title = {Neuroendocrine-immune perturbations in metabolic disease: pathophysiological mechanisms underlying cognitive impairment},
journal = {Frontiers in Human Neuroscience},
year = {2026},
volume = {20},
doi = {10.3389/fnhum.2026.1857087}
}
EUVIMED